Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

2.

Longitudinal Impact of Smoking and Smoking Cessation on Inflammatory Markers of Cardiovascular Disease Risk.

King CC, Piper ME, Gepner AD, Fiore MC, Baker TB, Stein JH.

Arterioscler Thromb Vasc Biol. 2017 Feb;37(2):374-379. doi: 10.1161/ATVBAHA.116.308728. Epub 2016 Dec 8.

PMID:
27932354
3.

Smoking Status Effect on Inflammatory Markers in a Randomized Trial of Current and Former Heavy Smokers.

Aldaham S, Foote JA, Chow HH, Hakim IA.

Int J Inflam. 2015;2015:439396. doi: 10.1155/2015/439396. Epub 2015 Aug 23.

4.

Depression is the strongest predictor of long-term outcome in patients with chronic nonischemic heart failure.

Szyguła-Jurkiewicz B, Zakliczyński M, Ploch M, Mościński M, Partyka R, Wojnicz R, Zembala M, Poloński L.

Kardiochir Torakochirurgia Pol. 2014 Mar;11(1):102-8. doi: 10.5114/kitp.2014.41942. Epub 2014 Mar 27.

5.

Association of exome sequences with plasma C-reactive protein levels in >9000 participants.

Schick UM, Auer PL, Bis JC, Lin H, Wei P, Pankratz N, Lange LA, Brody J, Stitziel NO, Kim DS, Carlson CS, Fornage M, Haessler J, Hsu L, Jackson RD, Kooperberg C, Leal SM, Psaty BM, Boerwinkle E, Tracy R, Ardissino D, Shah S, Willer C, Loos R, Melander O, Mcpherson R, Hovingh K, Reilly M, Watkins H, Girelli D, Fontanillas P, Chasman DI, Gabriel SB, Gibbs R, Nickerson DA, Kathiresan S, Peters U, Dupuis J, Wilson JG, Rich SS, Morrison AC, Benjamin EJ, Gross MD, Reiner AP; Cohorts for Heart and Aging Research in Genomic Epidemiology; National Heart, Lung, and Blood Institute GO Exome Sequencing Project.

Hum Mol Genet. 2015 Jan 15;24(2):559-71. doi: 10.1093/hmg/ddu450. Epub 2014 Sep 3.

6.

Evolution of lipid management guidelines: evidence might set you free.

Bosomworth NJ.

Can Fam Physician. 2014 Jul;60(7):612-7, e333-9. Review. English, French.

7.

Effect of increased leptin and C-reactive protein levels on mortality: results from the National Health and Nutrition Examination Survey.

Amrock SM, Weitzman M.

Atherosclerosis. 2014 Sep;236(1):1-6. doi: 10.1016/j.atherosclerosis.2014.06.009. Epub 2014 Jun 23.

8.

Effects of PPARγ and RBP4 gene variants on metabolic syndrome in HIV-infected patients with anti-retroviral therapy.

Hung YP, Lee NY, Lin SH, Chang HC, Wu CJ, Chang CM, Chen PL, Lin HJ, Wu YH, Tsai PJ, Tsai YS, Ko WC.

PLoS One. 2012;7(11):e49102. doi: 10.1371/journal.pone.0049102. Epub 2012 Nov 7.

9.

Relation of resistin levels with C-reactve protein, homocysteine and uric acid in smokers and non-smokers.

Esbah O, Gürsoy G, Kirnap NG, Cetiner H, Demirbaş B, Acar Y, Bayram M.

J Res Med Sci. 2011 Oct;16(10):1273-9.

10.

Genome-wide association and population genetic analysis of C-reactive protein in African American and Hispanic American women.

Reiner AP, Beleza S, Franceschini N, Auer PL, Robinson JG, Kooperberg C, Peters U, Tang H.

Am J Hum Genet. 2012 Sep 7;91(3):502-12. doi: 10.1016/j.ajhg.2012.07.023. Epub 2012 Aug 30.

11.

Relationships among changes in C-reactive protein and cardiovascular disease risk factors with lifestyle interventions.

Young D, Camhi S, Wu T, Hagberg J, Stefanick M.

Nutr Metab Cardiovasc Dis. 2013 Sep;23(9):857-63. doi: 10.1016/j.numecd.2012.05.003. Epub 2012 Jul 24.

12.

Low-dose nonlinear effects of smoking on coronary heart disease risk.

Cox LA Jr.

Dose Response. 2012;10(2):219-32. doi: 10.2203/dose-response.11-038.Cox. Epub 2011 Oct 14.

13.

Circulating, imaging, and genetic biomarkers in cardiovascular risk prediction.

Ge Y, Wang TJ.

Trends Cardiovasc Med. 2011 May;21(4):105-12. doi: 10.1016/j.tcm.2012.03.007. Review.

14.

White blood cell global methylation and IL-6 promoter methylation in association with diet and lifestyle risk factors in a cancer-free population.

Zhang FF, Santella RM, Wolff M, Kappil MA, Markowitz SB, Morabia A.

Epigenetics. 2012 Jun 1;7(6):606-14. doi: 10.4161/epi.20236. Epub 2012 Jun 1.

15.
16.
17.

Effects of smoking intensity and cessation on inflammatory markers in a large cohort of active smokers.

Asthana A, Johnson HM, Piper ME, Fiore MC, Baker TB, Stein JH.

Am Heart J. 2010 Sep;160(3):458-63. doi: 10.1016/j.ahj.2010.06.006.

18.

Ischaemic heart disease--a new issue in cystic fibrosis?

Perrin FM, Serino W.

J R Soc Med. 2010 Jul;103 Suppl 1:S44-8. doi: 10.1258/jrsm.2010.s11010. No abstract available.

19.

Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients.

Tziomalos K, Dimitroula HV, Katsiki N, Savopoulos C, Hatzitolios AI.

Mediators Inflamm. 2010;2010:364957. doi: 10.1155/2010/364957. Epub 2010 Mar 7. Review.

20.

Potential mediators of diabetes-related hearing impairment in the U.S. population: National Health and Nutrition Examination Survey 1999-2004.

Bainbridge KE, Cheng YJ, Cowie CC.

Diabetes Care. 2010 Apr;33(4):811-6. doi: 10.2337/dc09-1193. Epub 2010 Jan 22.

Supplemental Content

Support Center